UFRACTION8 LIMITED

Active Falkirk
3 employees website.com
Life sciences and medical technology
U

UFRACTION8 LIMITED

Founded 6 Apr 2017 Active Falkirk, Scotland 3 employees website.com
Life sciences and medical technology
Accounts Submitted 5 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 7 May 2026 Next due 9 Mar 2027 9 months remaining
Net assets £662K £70K 2023 year on year
Total assets £673K £80K 2023 year on year
Total Liabilities £11K £10K 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Suite 1/14 45 Vicar Street Falkirk FK1 1LL Scotland

Telephone

0800 000 0000

Website

www.example.com

Full company profile for UFRACTION8 LIMITED (SC562625), an active life sciences and medical technology company based in Falkirk, Scotland. Incorporated 6 Apr 2017. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2018–2023)

Cash in Bank

£111.35k

Decreased by £177.05k (-61%)

Net Assets

£661.79k

Decreased by £70.15k (-10%)

Total Liabilities

£11.31k

Decreased by £10.00k (-47%)

Turnover

N/A

Employees

3

Decreased by 2 (-40%)

Debt Ratio

2%

Decreased by 1 (-33%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1
Grants 5

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Feb 2025Venture - Series Unknown
Investor 2Feb 2025Venture - Series Unknown

Share Capital

Share Capital

Share allotments and capital structure

13 Allotments 641,284 Shares £2.96m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
23 Dec 2024330,275£1.08m£3.27
23 Dec 2024253,035£792k£3.13
4 Jan 20231,192£32k£26.846
14 Dec 20226,112£164k£26.832
7 Dec 20223,130£84k£26.837

Officers

Officers

1 active 2 resigned
Status
Tomecka, Monika Jagoda, DrDirectorPolishScotland366 Apr 2017Active

Shareholders

Shareholders (19)

Monika Jagoda Tomecka
20.5%
396,950
Heriot-watt Universitys
12.4%
240,000

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Brian Miller

Ceased 23 Dec 2024

Ceased

Monika Jagoda Tomecka

Ceased 23 Dec 2024

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
7 May 2026Confirmation StatementConfirmation statement made on 23 Feb 2026 with updates
3 Dec 2025OfficersTermination of Sandy Blackadder Primrose as director on 30 Nov 2025
24 Sept 2025CapitalCapital Return Purchase Own Shares
23 Sept 2025CapitalCapital Cancellation Shares
18 Sept 2025CapitalCapital Name Of Class Of Shares
7 May 2026 Confirmation Statement

Confirmation statement made on 23 Feb 2026 with updates

3 Dec 2025 Officers

Termination of Sandy Blackadder Primrose as director on 30 Nov 2025

24 Sept 2025 Capital

Capital Return Purchase Own Shares

23 Sept 2025 Capital

Capital Cancellation Shares

18 Sept 2025 Capital

Capital Name Of Class Of Shares

Recent Activity

Latest Activity

Confirmation statement made on 23 Feb 2026 with updates

1 months ago on 7 May 2026

Termination of Sandy Blackadder Primrose as director on 30 Nov 2025

6 months ago on 3 Dec 2025

Capital Return Purchase Own Shares

8 months ago on 24 Sept 2025

Capital Cancellation Shares

8 months ago on 23 Sept 2025

Capital Name Of Class Of Shares

8 months ago on 18 Sept 2025